GMED Operating Margin
20.75%TTM
Period ending:
GMED FY Operating Margin%
35.28%3.51%
2009-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
GMED operating margin history
Operating income as a percentage of revenue. The available annual fiscal periods series contains 17 observations from Dec 31, 2009 to Dec 31, 2025.
| Period ending | Operating Margin |
|---|---|
| 16.3258% | |
| 6.5886% | |
| 8.4886% | |
| 22.286% | |
| 17.9473% | |
| 14.1226% | |
| 21.8992% | |
| 23.7493% | |
| 25.4475% | |
| 27.3303% | |
| 31.6147% | |
| 29.1675% | |
| 23.4022% | |
| 29.7396% | |
| 29.3721% | |
| 30.4256% | |
| 32.2025% |
Compare operating margin
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) operating margin
- HSBC Holdings, plc. Common Stock (HSBC) operating margin
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) operating margin
- Novartis AG Common Stock (NVS) operating margin
- Royal Bank Of Canada Common Stock (RY) operating margin
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) operating margin
- SAP SE ADS (SAP) operating margin
- AstraZeneca PLC Ordinary Shares (AZN) operating margin
Compare all covered stocks by operating margin →
All GMED financial metrics · GMED stock overview · How to interpret financial metrics
